Different cells in our pancreas perform critical functions in blood sugar regulation. The gene neurogenin 3 (NEUROG3) is discovered in pancreatic cells. Its mutant version may induce diabetes.
Different cells in our pancreas play crucial roles in regulating our blood sugar. Neurogenin 3 (NEUROG3) is the name of a gene found in pancreatic cells. The mutated form of it may cause diabetes.
New Delhi [India], July 6: Vedam Gastro Hospital, one of the best gastro hospitals in Surat, is proud to announce the collaboration of four renowned gastroenterologists, Dr Pallav Parikh, Dr Pravin Borasadia, Dr Ronak Malani, and Dr Pintu Bhakhar. With a combined experience of 30 years and a
The researchers have combined the fuel cell with artificial beta cells developed by their group several years ago. These produced insulin at the touch of a button and effectively lower blood glucose levels much like their natural role models in the pancreas.
Despite advances in pancreatic cancer treatment, only around 9% of patients live beyond five years. Researchers have failed to identify genetic distinctions that explain why some patients live for a long time and others do not, so they have moved their focus to the gut microbiome.
A diet high in vitamin A or its analogues may help prevent children and young adults with acute lymphoblastic leukaemia (ALL) from developing painful pancreas inflammation during chemotherapy.
According to a new study, an artificial pancreas created at the University of Virginia Center for Diabetes Technologies improves blood sugar management in children aged 2 to 6 with type 1 diabetes.
In the pancreas, various types of beta cells produce insulin, which aids in blood sugar regulation. According to Weill Cornell Medicine researchers, losing a particularly productive type of beta cell may contribute to the development of diabetes.
A diet high in vitamin A or its analogues may assist children and teenagers with acute lymphoblastic leukaemia (ALL) lower their likelihood of experiencing uncomfortable pancreatic inflammation during chemotherapy.
person with Type 1 diabetes has a smaller pancreas than someone without the disease. This is unexpected because insulin-producing beta cells make up a very minor portion of the pancreas and their loss in Type 1 diabetes would not be anticipated to result in a reduction in pancreas size.
In Phase 3 clinical trial for metastatic pancreatic ductal adenocarcinoma, a four-drug chemotherapy treatment led to a longer overall survival than a two-drug combination.